As we approach 2026, the field of spatial biology has moved from emerging to essential. For research teams aiming to integrate these powerful techniques, selecting the right partner is a critical decision. The process involves more than comparing prices; it requires a careful evaluation of a spatial omics service against the specific needs of your project and the long-term goals of your lab. At STOmics, we understand these considerations from both sides of the collaboration. Based on our experience, we suggest focusing on three core areas when assessing a potential spatial transcriptomics service provider.

Evaluating Technological Depth and Flexibility

The foundation of any strong partnership is the technology itself. A capable spatial transcriptomics service provider should offer more than a single application. Inquire about the core technology's resolution, sensitivity, and multiplexing capability. Can it achieve true whole-transcriptome profiling at single-cell level? Does it allow for multi-omics integration, such as combining transcriptome and proteome data from the same section? Furthermore, assess the platform's flexibility in terms of tissue type compatibility and field of view. A provider with a robust, well-published, and adaptable platform, like the Stereo-seq technology utilized in our work at STOmics, ensures your project isn't limited by methodological constraints from the start. This technological depth is what transforms a simple service into a true research accelerator.

Assessing Scientific Support and Collaborative Partnership

Beyond the technical specifications, the quality of scientific partnership defines the experience. A reliable spatial omics service is built on expert support that begins during experimental design. Look for a provider whose team engages deeply with your biological questions to help optimize sample preparation, staining panels, and analysis pathways. Consider their bioinformatics support: is raw data delivery the end point, or do they offer robust, validated pipelines and software for in-depth spatial analysis? The ideal provider acts as an extension of your team, offering insights drawn from a broad portfolio of projects. Their scientists should be published leaders, contributing to the field through work in major journals and international consortia, indicating a commitment to driving science forward, not just processing samples.

Considering Platform Accessibility and Future-Readiness

Finally, think about the long-term trajectory for your spatial biology work. Will this engagement provide access to a mature spatial omics service and also equip your lab for future independence? Evaluate if the provider offers a complete ecosystem, from specialized hardware and consumables to analysis solutions, allowing for a potential transition to in-house capability if needed. Additionally, a forward-looking provider continuously advances its platform, offering roadmap insights into higher resolutions, larger capture areas, and novel multi-omic applications. Choosing a partner invested in continuous innovation ensures your research remains at the forefront, leveraging the latest advancements in spatial biology to maintain a competitive edge.

Selecting a spatial transcriptomics service provider is an investment in your research outcomes. By thoroughly examining the technological foundation, the depth of scientific collaboration, and the pathway for future growth, you can establish a partnership that delivers reliable data and genuine insight. Our goal at STOmics is to be that partner, providing an advanced, end-to-end spatial multi-omics platform alongside the expert support that turns complex data into clear biological discovery. We believe this integrated approach is key to a successful and productive spatial omics service relationship.